Personalis Inc Sustainability Reports
Personalis, Inc. provides advanced genomic sequencing and analytics solutions for precision oncology and cancer management. Its specialized assays are designed to detect minimal residual disease, monitor therapy response, and guide personalized treatment selection.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300EZ2NYFK7H0US48
FIGI: BBG0027NWBS7
3 reports from 2020 to 2024
